Contaminated Incubators: Source of a Multispecies Enterobacter Outbreak of Neonatal Sepsis.

Enterobacter Enterobacter bugandensis NICU outbreak bloodstream infections health care-associated infections infection control sepsis very low birth weight (VLBW) infants

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
31 08 2022
Historique:
pubmed: 16 6 2022
medline: 9 9 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

The genus Enterobacter includes species responsible for nosocomial outbreaks in fragile patients, especially in neonatal intensive care units (NICUs). Determining the primary source of infection is critical to outbreak management and patient outcomes. In this investigation, we report the management and control measures implemented during an Enterobacter outbreak of bloodstream infections in premature babies. The study was conducted in a French NICU over a 3-year period (2016 to 2018) and included 20 premature infants with bacteremia. The clinical and microbiological characteristics were identified, and whole-genome sequencing (WGS) was performed on bacteremia isolates. Initially, several outbreak containment strategies were carried out with no success. Next, outbreak investigation pinpointed the neonatal incubators as the primary reservoir and source of contamination in this outbreak. A new sampling methodology during "on" or "in use" conditions enabled its identification, which led to their replacement, thus resulting in the containment of the outbreak. WGS analysis showed a multiclonal outbreak. Some clones were identified in different isolation sources, including patients and neonatal incubators. In addition, microbiological results showed a multispecies outbreak with a high prevalence of Enterobacter bugandensis and Enterobacter xiangfangensis. We conclude that the NICU health care environment represents an important reservoir for Enterobacter transmission and infection. Finally, extracting samples from the neonatal incubator during active use conditions improves the recovery of bacteria from contaminated equipment. This method should be used more frequently to achieve better monitoring of the NICU for HAIs prevention.

Identifiants

pubmed: 35703554
doi: 10.1128/spectrum.00964-22
pmc: PMC9430301
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0096422

Références

Future Microbiol. 2012 Jul;7(7):887-902
pubmed: 22827309
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1470-5
pubmed: 23302685
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Pediatr Res. 2021 Dec;90(6):1215-1220
pubmed: 33627818
Am J Perinatol. 2020 Jan;37(2):166-173
pubmed: 31039596
Antimicrob Agents Chemother. 2002 Sep;46(9):2797-803
pubmed: 12183231
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30745327
J Hosp Infect. 2020 Feb;104(2):144-149
pubmed: 31525448
iScience. 2021 Jul 30;24(8):102916
pubmed: 34409274
Infect Control Hosp Epidemiol. 2003 Jul;24(7):490-4
pubmed: 12887236
Lancet Microbe. 2021 Oct;2(10):e536-e544
pubmed: 35544179
Am J Infect Control. 2000 Jun;28(3):258-61
pubmed: 10840347
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31685460
Genome Res. 2017 May;27(5):768-777
pubmed: 28232478
J Antimicrob Chemother. 2015 Apr;70(4):1008-15
pubmed: 25558071
Pediatrics. 2012 Apr;129(4):e1104-9
pubmed: 22451708
Clin Infect Dis. 2004 Jun 15;38(12):1682-7
pubmed: 15227612
Rev Esc Enferm USP. 2019 Aug 19;53:e03486
pubmed: 31433016
J Pediatr. 2018 Oct;201:106-114.e4
pubmed: 30054165
Antimicrob Resist Infect Control. 2018 Mar 9;7:36
pubmed: 29556377
Lancet. 2000 Mar 18;355(9208):973-8
pubmed: 10768436
J Clin Microbiol. 2000 May;38(5):1791-6
pubmed: 10790101
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Microbiol Spectr. 2021 Dec 22;9(3):e0138021
pubmed: 34817232
Int J Antimicrob Agents. 2011 Sep;38(3):265-9
pubmed: 21752606
Int J Syst Evol Microbiol. 2016 Feb;66(2):968-974
pubmed: 26637818
Pediatrics. 2002 Aug;110(2 Pt 1):285-91
pubmed: 12165580
J Hosp Infect. 2008 Sep;70(1):7-14
pubmed: 18632183
Early Hum Dev. 2014 Mar;90 Suppl 1:S4-6
pubmed: 24709456
Am J Infect Control. 2005 Jun;33(5):268-75
pubmed: 15947743
Sci Rep. 2018 Mar 29;8(1):5392
pubmed: 29599516
BMC Infect Dis. 2020 Sep 17;20(1):682
pubmed: 32942989
Microbiol Spectr. 2021 Dec 22;9(3):e0124221
pubmed: 34937187
Clin Microbiol Rev. 2019 Jul 17;32(4):
pubmed: 31315895
J Infect Public Health. 2014 Jul-Aug;7(4):339-44
pubmed: 24861643
J Hosp Infect. 2021 Oct;116:87-90
pubmed: 34419520
Am J Infect Control. 2001 Jun;29(3):133-8
pubmed: 11391273
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Eur J Pediatr. 2019 Apr;178(4):505-513
pubmed: 30671695
Pediatr Infect Dis J. 2019 Jun;38(6):631-637
pubmed: 30550512
Pediatr Neonatol. 2009 Feb;50(1):3-7
pubmed: 19326831
Clin Microbiol Infect. 2018 Apr;24(4):350-354
pubmed: 29309930

Auteurs

Enrique Hernandez-Alonso (E)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.

Nadège Bourgeois-Nicolaos (N)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.
Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Margaux Lepainteur (M)

Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Véronique Derouin (V)

Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Simon Barreault (S)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.

Adam Waalkes (A)

Department of Laboratory Medicine and Pathology, University of Washingtongrid.34477.33, Seattle, Washington, USA.

Luis A Augusto (LA)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.

Stuti Gera (S)

Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Orane Gleizes (O)

Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Pierre Tissieres (P)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.

Stephen J Salipante (SJ)

Department of Laboratory Medicine and Pathology, University of Washingtongrid.34477.33, Seattle, Washington, USA.

Daniele de Luca (D)

Department of Neonatal Intensive Care, L'Assistance Publique-Hôpitaux De Paris, Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.
Physiopathology and Therapeutic Innovation Unit, INSERM U999, Paris-Saclay University, Le Kremlin-Bicêtre, France.

Florence Doucet-Populaire (F)

Institute of Integrative Biology of the Cell (I2BC), CNRS, CEA, Paris-Saclay University, Gif-sur-Yvette, France.
Department of Bacteriology-Hygiene, AP-HP Paris-Saclay University, Hôpital Antoine Béclère, Clamart, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH